Cstone Pharmaceuticals Co. Ltd. is an investment holding company, which engages in the research and development of complex biopharmaceutical products and sale of pharmaceutical products. The company is headquartered in Suzhou, Jiangsu and currently employs 135 full-time employees. The company went IPO on 2019-02-26. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The firm conducts its businesses mainly in domestic market.
Follow-Up Questions
Who is the CEO of CStone Pharmaceuticals?
Dr. Jianxin Yang is the Chief Executive Officer of CStone Pharmaceuticals, joining the firm since 2016.
What is the price performance of CSPHF stock?
The current price of CSPHF is $0.855, it has decreased 0% in the last trading day.
What are the primary business themes or industries for CStone Pharmaceuticals?
CStone Pharmaceuticals belongs to Biotechnology industry and the sector is Health Care
What is CStone Pharmaceuticals market cap?
CStone Pharmaceuticals's current market cap is $1.2B
Is CStone Pharmaceuticals a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for CStone Pharmaceuticals, including 2 strong buy, 4 buy, 1 hold, 0 sell, and 2 strong sell
